Revolution Medicines' potential breakthrough pancreatic cancer drug succeeds in late-stage trial
--------------------------------------------------------------------
Source: CNBC
Published: 2026-04-13 22:00 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Law & Courts, Drugs, Crime & Justice
--------------------------------------------------------------------
Snippet:
Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, almost doubling the typical length of survival and slashing the risk of death by 60% versus chemotherapy, the company said Monday.
--------------------------------------------------------------------